echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Explore the headline Cell sub-published two articles in a row: Islet stem cell transplantation is expected to end type 1 diabetes

    Explore the headline Cell sub-published two articles in a row: Islet stem cell transplantation is expected to end type 1 diabetes

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diabetes is a chronic disease that affects more than 460 million people worldwide
    .


    It is estimated that there are more than 113.


    The journal Cell Stem Cell published an article titled “ Cell Stem Cell Cell Stem Cell Implanted pluripotent stem-cell-derivedpancreatic endoderm cells secrete glucose-responsive C-peptide in patients withtype 1 diabetes Implanted pluripotent stem-cell-derivedpancreatic endoderm cells secrete glucose-responsive C-peptide in patients withtype 1 diabetes " research paper


    In " the Cell Reports Medicine on the" journal published in " the Cell Reports Medicine the Cell Reports Medicine Insulinexpression and C-Peptide in of the type 1 Diabetes Subjects Implanted with StemCell-derived pancreatic endoderm cells in AN encapsulation Device Insulinexpression and C-Peptide in of the type 1 Diabetes Subjects The study "implanted with stemcell-derived pancreatic endoderm cells in an encapsulation device " further explained that 63% of PEC-01 cells were implanted and insulin expression observed 3-12 months after implantation in the body


    End

    Reference materials:

    Reference materials:

    [1] https://doi.


    org /10.
    1016/j.
    stem.
    2021.


    [1] https://doi.


    [2] https://doi.
    org/10.
    1016/j.
    xcrm.
    2021.
    100466 https://doi.
    org/10.
    1016/j.
    xcrm.
    2021.
    100466 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.